https://afrezza.com/
Take Control with Afrezza® Rapid-acting Inhaled Insulin | Afrezza
Jun 19, 2026 - Afrezza® is the only rapid-acting inhaled insulin that delivers glucose management in moments for adults and children 6 years of age and older with diabetes.
take controlinhaled insulinrapidactingafrezza
https://www.goodrx.com/compare/precose-vs-afrezza
Precose vs. Afrezza for Diabetes Type 2: Important Differences and Potential Risks.
Compare Precose and Afrezza side effects, costs and risks for treating Diabetes Type 2.
diabetes type 2
https://www.news-medical.net/news/20140811/Sanofi-MannKind-sign-licensing-agreement-to-develop-and-commercialize-Afrezza-Inhalation-Powder.aspx
Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder
Jun 19, 2019 - Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of...
licensing agreementto develop
https://www.goodrx.com/afrezza/medicare-coverage
Afrezza Medicare Coverage and Co-Pay Details - GoodRx
Medicare coverage and pricing details for Afrezza. Learn more about Medicare prescription drug plans and savings with GoodRx.
medicare coverageafrezzapaydetailsgoodrx
https://www.medicaldaily.com/fda-approves-new-diabetes-drug-afrezza-inhalable-insulin-helps-diabetics-control-blood-sugar-290500
FDA Approves New Diabetes Drug, Afrezza; Inhalable Insulin Helps Diabetics Control Blood Sugar
Jun 28, 2014 - The FDA has finally approved a new diabetes drug that can be inhaled before or after eating, and can help patients control their blood sugar.
https://www.goodrx.com/compare/jardiance-vs-afrezza
Jardiance vs. Afrezza for Diabetes Type 2: Important Differences and Potential Risks.
Compare Jardiance and Afrezza side effects, costs and risks for treating Diabetes Type 2.
diabetes type 2